Srx Global Inc. (SRXH) intrinsic value & 10-year financials
Srx Global Inc. (SRXH) has a Graham intrinsic value of $0.36 per share. At $1.19 on Oct 17, 2026, the stock trades 231% above that value. Over the last 10 fiscal years revenue grew 271.9% a year to $6.5M, with an average return on invested capital of -30.8%.
- Graham intrinsic value
- $0.36
- Share price (Oct 17, 2026)
- $1.19
- Price vs Graham value
- 231% above
- Market cap
- $25.1M
- Revenue (FY2025)
- $6.5M
- Revenue growth (10-yr CAGR)
- 271.9%
- ROIC (10-yr avg)
- -30.8%
- Free cash flow (FY2025)
- —
SRXH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $6.5M | -$45.0M | -$2.13 | — | -174.6% | -432.1% |
| FY2024 | $35.0M | -$168.0K | -$0.01 | -$4.4M | -17.1% | -63.1% |
| FY2023 | $38.6M | -$22.8M | -$2.48 | $79.0K | -54.9% | -110.2% |
| FY2022 | $54.7M | -$39.3M | -$0.10 | -$20.8M | -71.0% | -101.6% |
| FY2021 | $46.0M | $3.4M | $0.01 | -$12.2M | -37.6% | -72.4% |
| FY2020 | $42.6M | -$59.3M | -$0.56 | -$7.7M | -64.2% | -223.9% |
| FY2019 | $15.6M | -$184.5M | — | -$21.1M | -233.2% | -317.9% |
| FY2018 | $14.8M | -$6.0M | — | -$6.9M | -34.9% | 849.7% |
| FY2017 | $1.7K | -$1.7M | -$0.00 | -$39.8K | -30221.3% | 83.1% |
| FY2016 | $48 | -$933.8K | -$0.00 | -$430.6K | -957670.8% | 80.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SRx Health Solutions, Inc. is a consistent compounder, expanding top-line revenue at 271.9% annually over the past decade.
SRx Health Solutions, Inc. has historically struggled to out-earn its cost of capital, averaging just -18.5% ROIC.
Over the decade, SRx Health Solutions, Inc. shows that management has aggressively returned capital to shareholders by retiring 97.7% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SRx Health Solutions, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.36 per share.